1. Home
  2. INTS vs NDLS Comparison

INTS vs NDLS Comparison

Compare INTS & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$3.33

Market Cap

13.7M

Sector

Health Care

ML Signal

HOLD

Logo Noodles & Company

NDLS

Noodles & Company

HOLD

Current Price

$12.21

Market Cap

68.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTS
NDLS
Founded
2012
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
13.7M
68.7M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
INTS
NDLS
Price
$3.33
$12.21
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
★ $19.33
N/A
AVG Volume (30 Days)
21.2K
★ 36.9K
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $495,089,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 0.37
52 Week Low
$0.22
$0.47
52 Week High
$8.06
$19.00

Technical Indicators

Market Signals
Indicator
INTS
NDLS
Relative Strength Index (RSI) 39.52 33.20
Support Level $3.15 $10.71
Resistance Level $4.17 $15.07
Average True Range (ATR) 0.33 0.80
MACD -0.01 -0.19
Stochastic Oscillator 16.84 4.96

Price Performance

Historical Comparison
INTS
NDLS

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services. It is focused on offering customers flavorful, cooked-to-order dishes in a warm and welcoming environment at an attractive value. It has approximately 340 company-owned restaurants and 83 franchise restaurants in 31 states.

Share on Social Networks: